CosmosStem cell kidneys prompt treatment hope | CosmosCosmosPetri dish organoids offer tantalising clues about the progress of hereditary kidney disease. Andrew Masterson reports.and more »… Continue reading
When the Microbiome Meets Cancer ImmunotherapyLWW JournalsRecent preclinical studies in animals have shown that anticancer immunotherapy by the anti-PD-L1 checkpoint inhibitor CTLA-4 relies on the presence of certain gut microbiota (Science 2015;350(… Continue reading
Futurity: Research NewsWater volume steers stem cells to become bone or fatFuturity: Research NewsAdding or removing water from a stem cell can direct them toward becoming either bone or fat, researchers report. Altering the volume of a cell changed it… Continue reading
Curetoday.comWhen to Stop Immunotherapy Treatment for MelanomaCuretoday.comWhen to Stop Immunotherapy Treatment for Melanoma. BY YANIA JANSEN. Yania Jansen, surgical trainee at Vrije Universiteit Brussel, in Brussels, Belgium, discusses the possibility… Continue reading
UPI.com |
DNA mutations shed in blood predicts response to immunotherapy in patients with cancer
Science Daily “We can help predict response to immunotherapy by measuring the number of mutations in circulating tumor DNA using a simple blood test,” said Yulian Khagi, MD, UC San Diego Moores Cancer Center fellow and first author. “Immunotherapy can result in … DNA mutations in blood predict response to immunotherapyUPI.com Study Demonstrates Potential for the Guardant360 Assay® to Predict Which Patients Will Benefit from ImmunotherapyMarkets Insider |
BioPharma-Reporter.com |
CSL adding scalable stem cell gene therapy tech in $91m Calimmune buy
BioPharma-Reporter.com According to spokeswoman Natalie de Vane, the acquisition is the first step into the cell and gene therapy space for CSL with the addition of an ex vivo hematopoietic stem cell (HSC) gene therapy candidate and R&D facilities in Pasadena, California … |
BioPharma-Reporter.com |
CGT Catapult teams with TrakCel for cell and gene therapy tracking
BioPharma-Reporter.com CGT Catapult announced its partnership with TrakCel this week, explaining the UK firm’s supply chain management platform will be used to track cell and gene therapies made at the facility and stored at an adjacent warehouse being built by Fisher … |
BioPharma-Reporter.com |
Dude where’s my CAR–T? Personalised meds need personalised logistics, says TrakCel
BioPharma-Reporter.com The approval of Novartis’ Kymriah (tisagenlecleucel) this week heralds a new era of personalised medicine, and – if Gilead’s $11.9bn Kite investment pays off – soon two chimeric antigen receptor (CAR) T-cell therapies could be available in the US. |